We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · October 14, 2020

CPX-351 Treatment in Secondary Acute Myeloblastic Leukemia Is Effective and Improves the Feasibility of Allogeneic Stem Cell Transplantation

Blood Cancer Journal

 

Additional Info

Disclosure statements are available on the authors' profiles:

Blood Cancer Journal
CPX-351 Treatment in Secondary Acute Myeloblastic Leukemia Is Effective and Improves the Feasibility of Allogeneic Stem Cell Transplantation: Results of the Italian Compassionate Use Program
Blood Cancer J 2020 Oct 06;[EPub Ahead of Print], F Guolo, L Fianchi, P Minetto, M Clavio, M Gottardi, S Galimberti, G Rizzuto, M Rondoni, G Bertani, M Dargenio, A Bilio, B Scappini, P Zappasodi, AM Scattolin, F Grimaldi, G Pietrantuono, P Musto, M Cerrano, S D'Ardia, E Audisio, A Cignetti, C Pasciolla, F Pavesi, A Candoni, C Gurreri, M Morselli, C Alati, N Fracchiolla, G Rossi, M Caizzi, F Carnevale-Schianca, A Tafuri, G Rossi, F Ferrara, L Pagano, RM Lemoli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading